A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Clinical trial NCT06616766 · RECRUITING

Trial details

NCT number: NCT06616766
Sponsor: Yuhan Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)Solid Tumor

Start date: 2024-10-02
Primary completion: 2028-03-15
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.